Home › Funds › Empery Asset Management, LP › NGEN
Empery Asset Management, LP position in NGEN
NERVGEN PHARMA CORP · Health Care
Empery Asset Management, LP reported holding 3,308,973 shares of NGEN (NERVGEN PHARMA CORP) in its Q3 2026 13F filing — a position valued at US$6.3M, representing 6.55% of its reported portfolio and ranking #5 among its reported holdings. Empery Asset Management, LP has disclosed NGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Empery Asset Management, LP's NGEN position evolved
Empery Asset Management, LP first disclosed a stake in NGEN in Q2 2026 at 4,000,000 shares (US$8.2M). Across 2 filings, Empery Asset Management, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,308,973 shares valued at US$6.3M — a reduction of -691,027 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 4.00M | $8.24M | New |
| Q3 2026 | 3.31M | $6.32M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NGEN and 13F data
NGEN (NERVGEN PHARMA CORP) is a Health Care company. 74 other funds we track also report a position in NGEN — the largest reported positions include DAFNA Capital Management LLC (US$2.2M), VALLEY FORGE INVESTMENT CONSULTANTS INC ADV (US$1.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NGEN
- DAFNA Capital Management LLC 1.05M sh · $2.16M · Q2 2026
- VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 834.16K sh · $1.59M · Q3 2026
More on Empery Asset Management, LP
FAQ
How long has Empery Asset Management, LP held NGEN?
Empery Asset Management, LP has disclosed NGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Empery Asset Management, LP's current position in NGEN?
As of Q3 2026, Empery Asset Management, LP holds 3.31M shares of NGEN (NERVGEN PHARMA CORP), valued at $6.32M, representing 6.55% of its reported portfolio and ranking #5.
Has Empery Asset Management, LP been buying or selling NGEN?
In the latest 13F filing (Q3 2026), Empery Asset Management, LP reduced its position in NGEN.
Which other funds hold NGEN?
Other major institutional holders of NGEN include DAFNA Capital Management LLC, VALLEY FORGE INVESTMENT CONSULTANTS INC ADV, among 74 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.